Dr. Tripathy on the Possibility of Curing Metastatic Breast Cancer

Debu Tripathy, MD
Published: Thursday, Feb 26, 2015


Debu Tripathy, MD, professor of medicine, chair, department of breast medical oncology, The University of Texas MD Anderson Cancer Center, discusses the possibility of one day being able to cure metastatic breast cancer.

Tripathy says he believes that one day, physicians will be able to cure metastatic breast cancer in the sense that the patient will be able to live a full life without symptoms, similar to how HIV patients live today.

While this is obtainable, Tripathy says it will take some time. Since cancer is not like a virus and come from our own bodies, researchers first need to better understand the inner-workings of cancer.

Tripathy says learning the aspects of tumor control, immunology, tissue-based research and collaboration among patients, physicians, government and pharmaceutical industries are key to realizing this dream.


Debu Tripathy, MD, professor of medicine, chair, department of breast medical oncology, The University of Texas MD Anderson Cancer Center, discusses the possibility of one day being able to cure metastatic breast cancer.

Tripathy says he believes that one day, physicians will be able to cure metastatic breast cancer in the sense that the patient will be able to live a full life without symptoms, similar to how HIV patients live today.

While this is obtainable, Tripathy says it will take some time. Since cancer is not like a virus and come from our own bodies, researchers first need to better understand the inner-workings of cancer.

Tripathy says learning the aspects of tumor control, immunology, tissue-based research and collaboration among patients, physicians, government and pharmaceutical industries are key to realizing this dream.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x